The expanding vaccine development pipeline, 1995–2008
- 3 February 2010
- Vol. 28 (5) , 1353-1356
- https://doi.org/10.1016/j.vaccine.2009.11.007
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate VaccineJAMA, 2006
- Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001Archives of Pediatrics & Adolescent Medicine, 2005
- Impact of Varicella Vaccination on Health Care UtilizationJAMA, 2005
- Factors Affecting U.S. Manufacturers’ Decisions To Produce VaccinesHealth Affairs, 2005
- Why Are Pharmaceutical Companies Gradually Abandoning Vaccines?Health Affairs, 2005
- Decline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United StatesNew England Journal of Medicine, 2005
- Decline in Varicella-Related Hospitalizations and Expenditures for Children and Adults After Introduction of Varicella Vaccine in the United StatesPediatrics, 2004
- Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus pneumoniae InfectionsPublished by American Medical Association (AMA) ,2004
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Childhood Vaccine Purchase Costs in the Public Sector: Past Trends, Future ExpectationsAmerican Journal of Public Health, 2002